KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Total Liabilities (2019 - 2025)

Hims & Hers Health's Total Liabilities history spans 7 years, with the latest figure at -$540.9 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 334.35% year-over-year to -$540.9 million; the TTM value through Dec 2025 reached -$540.9 million, down 334.35%, while the annual FY2025 figure was -$540.9 million, 334.35% down from the prior year.
  • Total Liabilities for Q4 2025 was -$540.9 million at Hims & Hers Health, down from $1.7 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.7 billion in Q3 2025 and bottomed at -$540.9 million in Q4 2025.
  • The 5-year median for Total Liabilities is $71.9 million (2022), against an average of $172.2 million.
  • The largest annual shift saw Total Liabilities crashed 675.7% in 2023 before it surged 1009.29% in 2025.
  • A 5-year view of Total Liabilities shows it stood at $86.0 million in 2021, then tumbled by 36.49% to $54.6 million in 2022, then soared by 77.94% to $97.2 million in 2023, then surged by 137.58% to $230.8 million in 2024, then plummeted by 334.35% to -$540.9 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Total Liabilities are -$540.9 million (Q4 2025), $1.7 billion (Q3 2025), and $1.3 billion (Q2 2025).